United States. Government Accountability Office. (2018). Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts: Report to congressional requesters. United States Government Accountability Office.
Chicago Style (17th ed.) CitationUnited States. Government Accountability Office. Food and Drug Administration: Information on Mifeprex Labeling Changes and Ongoing Monitoring Efforts: Report to Congressional Requesters. [Washington, D.C.]: United States Government Accountability Office, 2018.
MLA (9th ed.) CitationUnited States. Government Accountability Office. Food and Drug Administration: Information on Mifeprex Labeling Changes and Ongoing Monitoring Efforts: Report to Congressional Requesters. United States Government Accountability Office, 2018.